2010
DOI: 10.1007/s10147-010-0094-1
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

Abstract: Although moderate gastrointestinal toxicity was observed, oral CPA therapy contributed to improving the survival of heavily pretreated patients with recurrent epithelial ovarian cancer. A well-designed phase II trial in this regard is awaited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 20 publications
1
18
0
Order By: Relevance
“…Watanabe et al 21 conducted a feasibility study of 14 heavily pretreated patients with ovarian cancer, using oral cyclophosphamide 50 mg b.i.d. for 21 days every 28 days.…”
Section: Discussionmentioning
confidence: 99%
“…Watanabe et al 21 conducted a feasibility study of 14 heavily pretreated patients with ovarian cancer, using oral cyclophosphamide 50 mg b.i.d. for 21 days every 28 days.…”
Section: Discussionmentioning
confidence: 99%
“…[22][23][24][25] Although Cy is a widely used antineoplastic agent, its cytotoxicity is not limited to tumor tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Cy is one of the most common agents in the treatment of cancer [23] [24]. It has higher lethality towards rapidly proliferating cells, and this is not limited to tumor tissue.…”
Section: Discussionmentioning
confidence: 99%